Tuesday, November 24, 2009
UPDATE:Judge Dismisses Second Bellwether Case Involving Fosamax (Nasdaq)
(Updates with Merck comment.) NEW YORK -(Dow Jones)- A federal judge has dismissed the second of three so- called "bellwether" cases over Merck & Co.'s (MRK) osteoporosis drug Fosamax.